通过USP5介导的PD-L1二维基化调节了黑色素瘤免疫疗法的疗效
Jiaheng Xie1,2, Pengpeng Zhang3, Yuankun Liu4
1Department of Burns and Plastic Surgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, People's Republic of China.
Journal of translational medicine
|July 10, 2025
概括
USP5稳定PD-L1,促进黑色素瘤的免疫逃生. 抑制USP5通过减少瘤生长和促进T细胞活性来增强抗PD-1疗法,为黑色素瘤治疗提供了一种新的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 翻译后修饰 (PTMs) 在黑色素瘤免疫抵抗中的作用尚不清楚.
- 了解PD-L1调节中的PTM对于黑色素瘤进展至关重要.
- 在黑色素瘤中,PD-L1介导的免疫抵抗需要进一步的研究.
研究的目的:
- 确定黑色素瘤进展和免疫抵抗的关键调节者.
- 研究USP5在PD-L1稳定性和黑色素瘤中的作用.
- 确定是否针对USP5可以提高免疫疗法的疗效.
主要方法:
- 多omics分析和机器学习用于预后模型构建.
- 在体外和体内实验 (细胞培养,流细胞计,异位移植) 来研究USP5功能.
- 西方涂抹,共免疫沉,CHX追逐和泛定位测试以验证蛋白质相互作用和PD-L1稳定性.
主要成果:
- USP5被确定为一种二基化酶 (DUB),通过去除K48链接链来稳定PD-L1.
- USP5 Knockdown降低了PD-L1,增加了CD8+ T细胞透和激活,并抑制了黑色素瘤.
- 联合USP5敲击和抗PD-1疗法显著提高了疗效,减少了瘤负担并增强了T细胞激活.
结论:
- USP5通过duebiquitination稳定PD-L1促进黑色素瘤免疫逃生.
- USP5抑制是一种克服免疫检查点抑制剂 (ICI) 耐药性的新策略.
- 针对USP5具有改善黑色素瘤治疗患者结果的治疗潜力.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Covalently Linked Protein Regulators
7.3K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.3K
The Intrinsic Apoptotic Pathway
6.9K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.9K
Tumor Immunotherapy
665
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
665


